Evidence map›Paper›PMID 34534328›Full record

ArticleJapanese journal of clinical oncology2021

Erratum to: Fibroblast growth factor receptor 2 (FGFR2) fusions in Japanese patients with intrahepatic cholangiocarcinoma.

Masanori Tsujie, Tomohisa Iwai, Shoji Kubo, Takashi Ura, Etsuro Hatano, Daisuke Sakai, Yutaka Takeda, Masaki Kaibori, Tomoe Kobayashi, Akio Katanuma and 8 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Japanese journal of clinical oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Masanori TsujieDepartment of Surgery, Osaka Rosai Hospital, Osaka, Japan.ORCID 0000-0002-1265-3397
Tomohisa IwaiDepartment of Gastroenterology, Kitasato University Hospital, Sagamihara, Japan.
Shoji KuboDepartment of Hepato-Biliary-Pancreatic Surgery, Osaka City University Hospital, Osaka.
Takashi UraDepartment of Clinical Oncology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
Etsuro HatanoDepartment of Gastroenterological Surgery, Hyogo College of Medicine, Nishinomiya, Japan.
Daisuke SakaiDepartment of Gastroenterological Surgery, Osaka University Hospital, Suita, Japan.
Yutaka TakedaDepartment of Gastroenterological Surgery, Kansai Rosai Hospital, Amagasaki, Japan.
Masaki KaiboriDepartment of Surgery, Kansai Medical University, Osaka, Japan.
Tomoe KobayashiDepartment of Gastroenterology and Hematology, Tomakomai City Hospital, Tomakomai, Japan.
Akio KatanumaCenter for Gastroenterology, Teine-Keijinkai Hospital, Sapporo, Japan.
Yu KatayoseDepartment of Hepato-Biliary Pancreatic Surgery, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan.
Koji FukaseDepartment of Surgery, Japanese Red Cross Ishinomaki Hospital, Ishinomaki, Japan.
Naoki SakuraiDepartment of Surgery, Yamagata Prefectural Central Hospital, Yamagata, Japan.
Yukiko ItoDepartment of Gastroenterology, Japanese Red Cross Medical Center, Tokyo, Japan.
Fumiya SatoDepartment of Surgery, Kasugai Municipal Hospital, Kasugai, Japan.
Atsuyuki MaedaDepartment of Surgery, Ogaki Municipal Hospital, Ogaki, Japan.
Masanori AsadaDepartment of Gastroenterology and Hepatology, Japanese Red Cross Osaka Hospital, Osaka, Japan.
Chigusa MorizaneDepartment of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.

Funding

Taiho Pharmaceutical Co., Ltd
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34534328
PMCPMC8558910

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.